As Xarelto Lawsuit Filing Continue To Increase New Investigation Of Clinical Trials Takes Place

May 30, 2016 – – TheProductLawyers.com reports on the increasing number of lawsuits filed against the makers of Xarelto, Janssen Pharmaceuticals, a subdivision of the Johnson and Johnson Corporation, and Bayer AG. To date, there have been over 3,400 lawsuits filed since the drug’s approval by the U.S. Food and Drug Administration (FDA) in 2011 and have uniformly and consistently named Janssen and Bayer as defendants.

Given the breadth of the number of cases and the commonalities among them, the cases were consolidated into two primary groups. The biggest is a multidistrict litigation (MDL) numbering over 2,800 federally-filed cases that were consolidated by the U.S. Judicial Panel on Multidistrict Litigation (JPML). The JPML assigned jurisdiction over these cases to the Honorable Judge Eldon Fallon in the Eastern District of Louisiana and has been given number 2592. The second group is one that numbers in excess of 600 cases and is a mass tort program in Philadelphia, PA that was grouped together by the Court of Common Pleas.

When Xarelto was released on the market in 2011 it was a very highly rated, new-generation blood thinner drug with consumers since it accorded them more freedoms than the preceding types of blood-thinning drugs. It was FDA approved to treat patients recovering from hip or knee replacement surgeries as well as those suffering from deep vein thrombosis, pulmonary embolism, and a common heart condition known as atrial fibrillation. However, since that time, and in addition to the lawsuits filed, it has become the focus a number of investigations related to the clinical trials as well as a defective medical device.

Another development and probably one of the most ominous and telling indication of the future of Xarelto are the two “black box” warnings the drug has received from the FDA. These warnings are the harshest and most severe warnings that can be issued to a product prior to its potential removal from the consumer market.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010280